News and Events
Stay up to date on our current affairs.
MT Pharma America to Present Data on Investigational Edaravone and Amyotrophic Lateral Sclerosis at the 2017 American Academy of Neurology Annual Meeting
12-month Edaravone Clinical Study Data in ALS Presented at the 27th International Symposium on ALS/MND
The ALS Association Welcomes MT Pharma America as National Corporate Sponsor
FDA Accepts Mitsubishi Tanabe Pharma’s NDA Filing for Edaravone to Treat ALS
Mitsubishi Tanabe Pharma Submits New Drug Application for Edaravone to Treat ALS in the United States
Mitsubishi Tanabe Pharma Corporation Presents Edaravone Clinical Trial Data in ALS at 2016 American Academy of Neurology Annual Meeting